| Q55497286 | Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer. |
| Q35954736 | Cellular and mitochondrial iron homeostasis in vertebrates |
| Q93162311 | Classical and intermediate monocytes scavenge non-transferrin-bound iron and damaged erythrocytes |
| Q93155823 | Crosstalk of Nrf2 with the Trace Elements Selenium, Iron, Zinc, and Copper |
| Q37694191 | Diabetes in HFE Hemochromatosis. |
| Q38062233 | H(+)-coupled divalent metal-ion transporter-1: functional properties, physiological roles and therapeutics. |
| Q36067702 | Hepatocyte divalent metal-ion transporter-1 is dispensable for hepatic iron accumulation and non-transferrin-bound iron uptake in mice |
| Q24646056 | Hereditary hemochromatosis in the post-HFE era |
| Q37605754 | Iron homeostasis in the liver |
| Q36177903 | Iron overload and cofactors with special reference to alcohol, hepatitis C virus infection and steatosis/insulin resistance |
| Q41875184 | Iron regulation by hepatocytes and free radicals |
| Q37603508 | Iron transport machinery of human cells: players and their interactions |
| Q64098992 | Iron uptake by ZIP8 and ZIP14 in human proximal tubular epithelial cells |
| Q91740203 | Iron-Induced Liver Injury: A Critical Reappraisal |
| Q36177913 | Liver iron transport |
| Q90347064 | Low DMT1 Expression Associates With Increased Oxidative Phosphorylation and Early Recurrence in Hepatocellular Carcinoma |
| Q27010510 | Mechanisms of mammalian iron homeostasis |
| Q37725581 | Pathophysiology of the Belgrade rat. |
| Q33712488 | Targeting Iron Homeostasis in Acute Kidney Injury |
| Q39975320 | The hereditary hemochromatosis protein, HFE, inhibits iron uptake via down-regulation of Zip14 in HepG2 cells |
| Q36967117 | ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders |
| Q34186426 | ZRT/IRT-like Protein 14 (ZIP14) Promotes the Cellular Assimilation of Iron from Transferrin |